蛋白质折叠
蛋白质聚集
伴侣(临床)
肌萎缩侧索硬化
生物
神经退行性变
神经毒性
细胞生物学
神经科学
疾病
化学
医学
毒性
病理
有机化学
作者
Nitu L. Wankhede,Mayur B. Kale,Aman B. Upaganlawar,Brijesh G. Taksande,Milind J. Umekar,Tapan Behl,Ahmed A. Abd El‐Latif,Prasanna Mohana Bhaskaran,Sudharshan Reddy Dachani,Aayush Sehgal,Sukhbir Singh,Neelam Sharma,Hafiz A. Makeen,Mohammed Albratty,Hamed Ghaleb Dailah,Saurabh Bhatia,Ahmed Al‐Harrasi,Simona Bungău
标识
DOI:10.1016/j.biopha.2022.112647
摘要
Protein misfolding causes aggregation and build-up in a variety of brain diseases. There are numeral molecules that are linked with the protein homeostasis mechanism. Molecular chaperones are one of such molecules that are responsible for protection against protein misfolded and aggregation-induced neurotoxicity. Many studies have explored the participation of molecular chaperones in Parkinson’s disease, Alzheimer’s disease, Amyotrophic lateral sclerosis, and Huntington’s diseases. In this review, we highlighted the constructive role of molecular chaperones in neurological diseases characterized by protein misfolding and aggregation and their capability to control aberrant protein interactions at an early stage thus successfully suppressing pathogenic cascades. A comprehensive understanding of the protein misfolding associated with brain diseases and the molecular basis of involvement of chaperone against aggregation-induced cellular stress might lead to the progress of new therapeutic intrusion-related to protein misfolding and aggregation.
科研通智能强力驱动
Strongly Powered by AbleSci AI